Neurocrine stock took a hit late Thursday after the biotech company issued a light 2025 outlook for its drug, Ingrezza.

Greisner has a peanut allergy himself. He says the smell of peanuts could make people with allergies feel uncomfortable. Some ...

A man who ate up to nine pounds of cheese and butter every day developed yellow-colored nodules on his palms, soles, and ...

The American chocolatier records a $460 million pretax gain on commodity derivatives as cocoa futures hit record highs last ...